Trial intelligence / Profile preview

Keto Acid for Insulin Resistance in Peritoneal Dialysis Patients

NCT01496092Phase 3Completed

Sponsor
Peking University First Hospital
Start
Apr 2011
Primary completion
Dec 2012
Countries
1
01

Overview

A Phase 3 trial of Ketosteril in insulin resistance (IR), sponsored by Peking University First Hospital. Started Apr 2011; status: completed.

02

Drugs

Ketosteril
03

Conditions

insulin resistance (IR)

Beyond the preview

Go deeper on NCT01496092.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01496092.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call